Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Med Res ; 51(7): 664-669, 2020 10.
Article in English | MEDLINE | ID: mdl-32654881

ABSTRACT

AIM/BACKGROUND: Although many agents have been tested as treatment options for caustic esophageal burn (CEB), none have successfully suppressed the formation of strictures. Thus,the purpose of this study was to determine the efficacy of Contractubex® gel (10% onion extract, 50 U/gr heparin, and 1% allantoin) in stricture preventing after CEB. METHODS: In this study, 24 Wistar-albino rats were divided into 4 groups. CEB was initiated with an instillation of 1 mL of 10% NaOH solution into the an isolated esophageal segment for 3 min. Group C (control) was uninjured and untreated. In Group CEB, was initiated but no treatment was given. In Groups CTX1 and CTX2, the animals received 100 and 200 mg/kg/d, respectively, of Contractubex® for 4 weeks via gavage after CEB was initiated. The stenosis indices (SI), histopathologic damage scores, tissue hydroxyproline (HP) levels, and weights of the rats were taken before the experiment and 4 weeks after the experiment. RESULTS: The Mean SI levels, HP levels, and histopathologic damage scores were statistically lower in Groups CTX1 and CTX2 when compared with Group CEB (p <0.05). The treatment groups increased in weight when compared to Group CEB. The results were similar between Group CTX1 and Group CTX2 (p >0,05); the efficacy of the treatment was not dose-dependent. CONCLUSION: For the first time, Contractubex® was used for its antifibrotic, antioxidant, anti-inflammatory, and wound healing effects to treat caustic esophageal burn in rats. It was effective in reducing stricture formation by decreasing the HP levels and histopathologic damage as well as preventing stenosis and weight gain in the treatment groups.


Subject(s)
Allantoin/therapeutic use , Burns, Chemical/drug therapy , Constriction, Pathologic/drug therapy , Esophageal Stenosis/drug therapy , Heparin/therapeutic use , Plant Extracts/therapeutic use , Allantoin/pharmacology , Animals , Burns, Chemical/pathology , Disease Models, Animal , Drug Combinations , Heparin/pharmacology , Male , Plant Extracts/pharmacology , Rats , Rats, Wistar
2.
Pan Afr Med J ; 26: 55, 2017.
Article in English | MEDLINE | ID: mdl-28451032

ABSTRACT

Laryngotracheoesophageal clefts (LTECs) are rare congenital defects that are often accompanied by additional anomalies. The major issues in the treatment of these patients are intraoperative exposure insufficiency, technical difficulty of the operation, and anesthesia problems originating from the respiratory tract. Problems originating from mechanical ventilation and respiratory tract, eating disorders and relapse of fistula are among the problems encountered following surgery. Most of the time, concomitant additional anomalies also worsen the clinical picture. It was our aim with these case reports to report our experience in two cases with Type IV LTEC ranging from the inoperable type IV LTEC due to additional anomalies mounted up to severe respiratory distress to the carina that we operated on with a single stage anterior cervicothoracic approach on its fifth day on life.


Subject(s)
Congenital Abnormalities/pathology , Esophageal Atresia/pathology , Larynx/abnormalities , Tracheoesophageal Fistula/pathology , Congenital Abnormalities/surgery , Esophageal Atresia/surgery , Humans , Infant, Newborn , Larynx/pathology , Larynx/surgery , Male , Tracheoesophageal Fistula/congenital , Tracheoesophageal Fistula/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...